BetterLife Pharma Inc. (CSE: BETR)
Canada
· Delayed Price · Currency is CAD
0.120
+0.005 (4.35%)
Nov 18, 2024, 10:22 AM EST
BetterLife Pharma Statistics
Total Valuation
BetterLife Pharma has a market cap or net worth of CAD 13.08 million. The enterprise value is 17.36 million.
Market Cap | 13.08M |
Enterprise Value | 17.36M |
Important Dates
The next estimated earnings date is Thursday, December 26, 2024.
Earnings Date | Dec 26, 2024 |
Ex-Dividend Date | n/a |
Share Statistics
Current Share Class | n/a |
Shares Outstanding | n/a |
Shares Change (YoY) | +20.64% |
Shares Change (QoQ) | +3.93% |
Owned by Insiders (%) | n/a |
Owned by Institutions (%) | n/a |
Float | 93.64M |
Valuation Ratios
PE Ratio | n/a |
Forward PE | n/a |
PS Ratio | n/a |
PB Ratio | n/a |
P/TBV Ratio | n/a |
P/FCF Ratio | n/a |
P/OCF Ratio | n/a |
PEG Ratio | n/a |
Enterprise Valuation
EV / Earnings | -3.55 |
EV / Sales | n/a |
EV / EBITDA | n/a |
EV / EBIT | n/a |
EV / FCF | n/a |
Financial Position
The company has a current ratio of 0.07
Current Ratio | 0.07 |
Quick Ratio | 0.02 |
Debt / Equity | n/a |
Debt / EBITDA | n/a |
Debt / FCF | n/a |
Interest Coverage | -15.15 |
Financial Efficiency
Return on Equity (ROE) | n/a |
Return on Assets (ROA) | -707.53% |
Return on Capital (ROIC) | n/a |
Revenue Per Employee | n/a |
Profits Per Employee | -697,751 |
Employee Count | 7 |
Asset Turnover | n/a |
Inventory Turnover | n/a |
Taxes
Income Tax | n/a |
Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +84.62% in the last 52 weeks. The beta is 1.42, so BetterLife Pharma's price volatility has been higher than the market average.
Beta (5Y) | 1.42 |
52-Week Price Change | +84.62% |
50-Day Moving Average | 0.12 |
200-Day Moving Average | 0.12 |
Relative Strength Index (RSI) | 38.78 |
Average Volume (20 Days) | 16,209 |
Short Selling Information
Short Interest | n/a |
Short Previous Month | n/a |
Short % of Shares Out | n/a |
Short % of Float | n/a |
Short Ratio (days to cover) | 0.94 |
Income Statement
Revenue | n/a |
Gross Profit | n/a |
Operating Income | -4.81M |
Pretax Income | -4.40M |
Net Income | -4.88M |
EBITDA | n/a |
EBIT | -4.81M |
Earnings Per Share (EPS) | -0.04 |
Balance Sheet
The company has 126,305 in cash and 1.03 million in debt, giving a net cash position of -908,028.
Cash & Cash Equivalents | 126,305 |
Total Debt | 1.03M |
Net Cash | -908,028 |
Net Cash Per Share | n/a |
Equity (Book Value) | -7.57M |
Book Value Per Share | -0.08 |
Working Capital | -5.81M |
Cash Flow
Operating Cash Flow | -2.51M |
Capital Expenditures | n/a |
Free Cash Flow | n/a |
FCF Per Share | n/a |
Margins
Gross Margin | n/a |
Operating Margin | n/a |
Pretax Margin | n/a |
Profit Margin | n/a |
EBITDA Margin | n/a |
EBIT Margin | n/a |
FCF Margin | n/a |
Dividends & Yields
BetterLife Pharma does not appear to pay any dividends at this time.
Dividend Per Share | n/a |
Dividend Yield | n/a |
Dividend Growth (YoY) | n/a |
Years of Dividend Growth | n/a |
Payout Ratio | n/a |
Buyback Yield | -20.64% |
Shareholder Yield | -20.64% |
Earnings Yield | -40.08% |
FCF Yield | n/a |
Stock Splits
This stock does not have any record of stock splits.
Last Split Date | n/a |
Split Type | n/a |
Split Ratio | n/a |
Scores
Altman Z-Score | n/a |
Piotroski F-Score | n/a |